These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18237686)

  • 21. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
    Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild therapeutic hypothermia in patients after out-of-hospital cardiac arrest due to acute ST-segment elevation myocardial infarction undergoing immediate percutaneous coronary intervention.
    Wolfrum S; Pierau C; Radke PW; Schunkert H; Kurowski V
    Crit Care Med; 2008 Jun; 36(6):1780-6. PubMed ID: 18496378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ruptured plaque is associated with larger infarct size following successful percutaneous coronary intervention in ST segment elevation acute myocardial infarction.
    Tanaka A; Shimada K; Namba M; Sano T; Sakamoto T; Akasaka T; Yoshikawa J
    Coron Artery Dis; 2009 Jun; 20(4):260-6. PubMed ID: 19424058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.
    Schwarz AK; Zeymer U
    Future Cardiol; 2009 Jan; 5(1):43-9. PubMed ID: 19371202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic time: the new gold standard for ST-segment elevation myocardial infarction care.
    Smalling RW
    J Am Coll Cardiol; 2009 Dec; 54(23):2154-6. PubMed ID: 19942087
    [No Abstract]   [Full Text] [Related]  

  • 26. Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention.
    Stone GW
    Circulation; 2008 Jul; 118(5):538-51. PubMed ID: 18663102
    [No Abstract]   [Full Text] [Related]  

  • 27. Contrast-enhanced magnetic resonance imaging guided decision making after primary percutaneous coronary intervention for acute ST-elevation inferior myocardial infarction.
    Sozzi FB; Iacuzio L; Civaia F; Dor V
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):463-5. PubMed ID: 18524614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
    Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
    Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction.
    Napodano M; Tarantini G; Ramondo A; Cacciavillani L; Corbetti F; Marra MP; Fraccaro C; Peluso D; Razzolini R; Iliceto S
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):44-50. PubMed ID: 19145116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW;
    Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Willis P; Voeltz MD
    Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction.
    Abbate A; Kontos MC; Biondi-Zoccai GG
    Eur Heart J; 2008 Aug; 29(15):1795-7. PubMed ID: 18617478
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Brzozowska-Czarnek A; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
    J Electrocardiol; 2009; 42(2):152-6. PubMed ID: 19167012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary intervention related delay in ST-segment elevation myocardial infarction patients.
    Terkelsen CJ; Sørensen JT; Nielsen TT; Boersma E
    J Am Coll Cardiol; 2009 Apr; 53(14):1244; author reply 1244-5. PubMed ID: 19341870
    [No Abstract]   [Full Text] [Related]  

  • 37. Elevated admission cardiac troponin T is associated with microvascular dysfunction in acute myocardial infarction treated with emergency angioplasty.
    Porto I; Burzotta F; Brancati M; Trani C; Lombardo A; Romagnoli E; Niccoli G; Leone AM; Natale L; Biasucci LM; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):664-8. PubMed ID: 19506520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to treatment and ST-segment resolution in high-risk patients with acute myocardial infarction transferred from community hospitals for coronary angioplasty after pharmacological treatment.
    Manari A; Tomasi C; Guiducci V; Zanoni P; Pignatelli G; Giacometti P
    J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):32-8. PubMed ID: 18268416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
    Kelbaek H; Terkelsen CJ; Helqvist S; Lassen JF; Clemmensen P; Kløvgaard L; Kaltoft A; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Hansen HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Thuesen L
    J Am Coll Cardiol; 2008 Mar; 51(9):899-905. PubMed ID: 18308157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.